This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Tue, 12/26/2023 - 21:36 December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography to Detects Aortic Stenosis Murmur Before and After Transcatheter Aortic Valve Replacement (TAVR).
milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management.
Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. A treatment for patients with aortic valve disease is surgical aortic valve replacement (SAVR).
milla1cf Mon, 05/06/2024 - 10:50 May 6, 2024 — Teleflex Incorporate , a leading global provider of medical technologies, today announced that the Wattson Temporary Pacing Guidewire limited market release has commenced at Columbia University Irving Medical Center. Teleflex received 510(k) clearance from the U.S. JACC Cardiovasc Interv.
milla1cf Tue, 04/30/2024 - 13:03 April 30, 2024 — The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with valve surgery rapidly shifting to more complex interventions frequently involving other concomitant procedures. and 4.1%, respectively.
Magenta's technology stands at the forefront of innovation in the MCS field and has the potential to significantly improve outcomes in patients with severe cardiovascular conditions,” said Eric Snyder, Partner, Venture Investments, Novo Holdings US. Early Feasibility Study with the HR-PCI indication in 2023.
While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.
Powered by Philips’ Fiber Optic RealShape (FORS) technology and exclusively compatible with Philips interventional systems, LumiGuide uses light reflected along an optical fiber inside a guidewire to generate 3D, high-resolution, color images of interventional devices (e.g.
Abbott recognized the unmet need for people with this condition and explored the use of our proven clip-based technology to find a truly life-changing intervention. Advances in Transcatheter Tricuspid Valve Technologies VIDEO: Tricuspid Device Clinical Trial Overview — Interview with Ori Ben-Yehuda, M.D.
Resource Multi-Valve Surgery Risk Calculator kchalko Mon, 04/22/2024 - 14:57 The expanding use of transcatheter valve technologies has changed the landscape in the treatment of valvular disease. Valve surgery is rapidly shifting to more complex scenarios that involve multiple valve interventions and concomitant procedures.
Additionally, the exhibit hall will provide an opportunity to discuss the latest cardiac CT technology innovations with vendors, while discussions in the poster area ofer a deep dive into current studies and applications of the latest products. AMA PRA Category 1 Credits; in addition, SCCT24 program planners note that 13.75 5:00 p.m.,
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
The CT data of aorta were collected before operation, and the aorta was reconstructed by Mimics software and printed with 3D printing technology. One case complicated with ventricular septal defect (VSD). The operation simulation was performed before operation to determine the best operation plan.
Our upcoming session is just around the corner, and we've gathered all the crucial information you need to stay at the forefront of this game-changing technology. Transcatheter Aortic Valve Implantation (TAVI) is a game-changer in cardiovascular care. Demystifying the #TAVIProcedure: Let's get straight to the heart of the matter.
This fellowship also will allow Dr. Fiedler and Dr. Folesani to learn novel techniques, adapt innovative technology, and receive training from expert mentors who are dedicated to the highest standards of cardiothoracic surgery. Folesani to attend STS 2023 in San Diego, and Dr. Fiedler to attend EACTS 2022 in Milan.
Exploiting PCCT technology with a high-pitch dual-source image acquisition may render an exceptionally high temporal resolution.We Exploiting PCCT technology with a high-pitch dual-source image acquisition may render an exceptionally high temporal resolution.We Diaphragm to brain coverage was obtained in an acquisition time of 1.3
28, 2024 — Cardiawave SA, developer of Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for treating severe symptomatic calcific aortic stenosis (CAS), announced that the device met the primary endpoint in its pivotal study and improved or stabilized heart failure symptoms for 80.5 2023, doi: 10.1016/j.acvd.2023.01.002.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content